Accessibility Menu

Scancell Plc(FRA) SCP

Market Cap€94.55MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPON/A
5 YearN/A
1 YearN/A
1 MonthN/A
€0.08
+1.93%
+0.00Today

Scancell Plc Financials at a Glance

Market Cap

€94.55MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

N/A

Net Income (TTM)

N/A

EPS (TTM)

-€0.01

P/E Ratio

-12.58

Dividend

€0.00

Beta (Volatility)

0.24 (Low)

Price

€0.08

Volume

0

Open

€0.08

Previous Close

€0.08

Daily Range

€0.08 - €0.08

52-Week Range

€0.06 - €0.29

Estimated Earnings Date

N/A

SCP News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Scancell Plc

Scancell Holdings Plc engages in the development of novel therapeutic vaccines for the treatment of cancer. Its vaccine platform includes Moditope and ImmunoBody. The company was founded by Lindy Gillian Durrant in 1997 and is headquartered in Oxford, the United Kingdom.

Industry

Biotechnology

CEO

Philip John L'Huillier, PhD, MBA

SCP Financials

Key Financial Metrics (TTM)

Gross Margin

N/A

Operating Margin

N/A

Net Income Margin

N/A

Return on Equity

0.00%

Return on Capital

N/A

Return on Assets

N/A

Earnings Yield

-7.95%

Dividend Yield

0.00%

Payout Ratio

N/A

Stock Overview

Market Cap

€94.55MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

1.21B

Volume

0

Avg. Volume

1.87K

Financials (TTM)

Gross Profit

N/A

Operating Income

N/A

EBITDA

N/A

Operating Cash Flow

N/A

Capital Expenditure

N/A

Free Cash Flow

N/A

Cash & ST Invst.

N/A

Total Debt

N/A

Scancell Plc Performance Analysis

Scancell Plc annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-04-30EUR 0N/A
20232023-04-30EUR 6,077,330N/A
20242024-04-30EUR 0N/A
20252025-04-30EUR 5,599,645N/A
Scancell Plc annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-04-30EUR -0.01N/A
20232023-04-30EUR -0.02156.1%
20242024-04-30EUR -0.01-53.3%
20252025-04-30EUR -0.0289.9%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
CurrentYOY CHG

Revenue

N/A

N/A

Gross Profit

N/A

N/A

Gross Margin

N/A

N/A

Market Cap

€94.55MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

N/A

N/A

Employees

N/A

N/A

Net Income

N/A

N/A

EBITDA

N/A

N/A

Quarterly Fundamentals

Name
CurrentYOY CHG

Total Cash

N/A

N/A

Total Debt

N/A

N/A

Accounts Receivable

N/A

N/A

Inventory

N/A

N/A

Long Term Debt

N/A

N/A

Short Term Debt

N/A

N/A

Return on Assets

N/A

N/A

Return on Invested Capital

N/A

N/A

Free Cash Flow

N/A

N/A

Operating Cash Flow

N/A

N/A

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
^GSPCS&P 500
$7,684.24-0.00%
^DJIDJI
$53,254.61-0.01%
^IXICNASDAQ
$26,319.55-0.00%
BTCBitcoin
$78,890.00-0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
PCGPG&E
$13.27-0.20%
NVDANvidia
$220.78+0.01%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$9.97+0.11%
CNHCNH Industrial
$11.83+0.01%

Questions About SCP

What is the current price of Scancell Plc?

Scancell Plc is trading at €0.08 per share.

What is the 52-week range for Scancell Plc?

Over the past 52 weeks, Scancell Plc has traded between €0.06 and €0.29.

How much debt does Scancell Plc have?

As of the most recent reporting period, Scancell Plc reported total debt of €19.11M.

How much cash does Scancell Plc have on hand?

Scancell Plc reported €19.85M in cash and cash equivalents in its most recent financial results.

What is Scancell Plc’s dividend yield?

Scancell Plc does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.